Anti-inflammation and PI3K-AKT/MTOR activation (Khan et al., 2016b) and multiple active ingredients of GQL that can synergize with numerous target proteins result in diverse beneficial mechanisms in the treatment T2DM. This evidence concerns the gene MTOR and type 2 diabetes mellitus.